Viruses,
Год журнала:
2024,
Номер
16(11), С. 1795 - 1795
Опубликована: Ноя. 19, 2024
Long
COVID
or
Post-Acute
Sequelae
of
SARS-CoV-2
infection
(PASC)
is
a
condition
characterized
by
numerous
lingering
symptoms
that
persist
for
weeks
to
months
following
the
viral
illness.
While
treatment
PASC
still
evolving,
several
therapeutic
approaches
beyond
traditional
antiviral
therapies
are
being
investigated,
such
as
immune-modulating
agents,
anti-inflammatory
drugs,
and
various
supportive
interventions
focusing
at
alleviating
enhancing
recovery.
We
aimed
summarize
breadth
available
evidence,
identify
knowledge
gaps,
highlight
promising
non-antiviral
COVID/PASC.
followed
framework
scoping
methodology
mapping
existing
evidence
from
range
studies,
including
randomized
clinical
trials,
observational
research,
case
series.
Treatments
evaluated
include
metformin,
low-dose
naltrexone
(LDN),
dexamethasone,
statins,
omega-3
fatty
acids,
L-arginine,
emerging
like
intravenous
immunoglobulin
(IVIg)
apheresis.
Early
findings
suggest
metformin
has
strongest
particularly
large
phase
3
while
LDN
dexamethasone
show
potential
based
on
studies.
However,
many
treatments
lack
robust,
large-scale
trials.
This
review
emphasizes
need
further
research
confirm
efficacy
these
guide
practice
management.
The Journal of Clinical Endocrinology & Metabolism,
Год журнала:
2023,
Номер
108(10), С. e1106 - e1116
Опубликована: Апрель 13, 2023
Long
COVID
is
an
emerging
syndrome
affecting
50%
to
70%
of
COVID-19
survivors
that
still
lacks
predicting
factors.Due
the
extraskeletal
effects
vitamin
D,
we
retrospectively
assessed
association
between
25(OH)
D
levels
and
long
in
6
months
after
hospitalization.Long
was
defined
according
NICE
guidelines.
Fifty
50
non-long-COVID
subjects
matched
on
a
1:1
basis
were
enrolled
from
outpatient
clinic
post-COVID
cohort
seen
August
November
2020.
Therapies/comorbidities
calcium/vitamin
D/bone
metabolism,
and/or
admission
intensive
care
unit
during
hospitalization
exclusion
criteria.
Vitamin
measured
at
hospital
discharge.We
observed
lower
levels,
evaluated
follow-up,
with
than
those
without
(20.1
vs
23.2
ng/mL,
P
=
.03).
Regarding
affected
health
areas
entire
cohort,
neurocognitive
symptoms
follow-up
(n
7)
93)
(14.6
20.6
.042).
In
patients
presenting
deficiency
(<20
ng/mL),
both
42),
by
22)
presented
not
20)
(12.7
15.2
.041).
multiple
regression
analyses,
only
variable
significantly
associated
our
(P
.008,
OR
1.09,
CI
1.01-1.16).COVID-19
have
COVID.
Our
data
suggest
should
be
discharge.
The
role
supplementation
as
preventive
strategy
sequelae
tested
randomized
controlled
trials.
Nutrients,
Год журнала:
2024,
Номер
16(8), С. 1144 - 1144
Опубликована: Апрель 12, 2024
Nowadays,
the
interest
in
extraskeletal
effects
of
vitamin
D
is
growing.
In
literature,
its
several
possible
actions
have
been
confirmed.
Vitamin
seems
to
a
regulatory
role
many
different
fields-inflammation,
immunity,
and
endocrine
system-and
studies
would
demonstrate
correlation
between
cardiovascular
disease.
this
paper,
we
deepened
relationship
dyslipidemia
by
reviewing
available
literature.
The
results
are
not
entirely
clear-cut:
on
one
hand,
numerous
observational
suggest
link
higher
serum
levels
beneficial
lipid
profile,
while
other
interventional
do
significant
effect.
Understanding
may
represent
turning
point:
another
system.
Frontiers in Nutrition,
Год журнала:
2025,
Номер
11
Опубликована: Янв. 7, 2025
Current
evidence
is
inconsistent
on
whether
vitamin
D
supplementation
can
prevent
COVID-19
infection
or
improve
its
clinical
outcomes.
To
better
understand
and
look
into
the
issue,
we
went
through
background
knowledge
of
D,
searched
in
Pubmed
[by
using
key
words
title
containing
"randomized
trial",
"COVID-19",
"vitamin
(25-hydroxyvitamin
cholecalciferol,
calcidiol,
calcifediol)
supplementation"]
for
publications
studies
D/supplementation
patients,
especially
those
about
randomized
trials
(RCTs).
After
reviewing
these
papers,
did
a
short
review
pathophysiology
COVID-19,
summarized
features
25
RCTs
text
tabulated
table
some
features,
commented,
compared
discussed
differences
between
(for
example,
change
serum
25-hydroxyvitamin
concentration
from
nmol/L
to
ng/mL,
making
comparison
easier).
The
take-home
question
that
an
important
indicator
effect
correction
but
may
not
be
reliable
predicting
outcomes
COVID-19.
Nutrients,
Год журнала:
2024,
Номер
16(9), С. 1349 - 1349
Опубликована: Апрель 29, 2024
Chronic
diseases
may
affect
the
nutritional
status
of
children
and
adolescents.
Calcium
(Ca),
phosphorus
(P),
vitamin
D
(Vit-D)
are
crucial
nutrients
for
their
growth
development.
Proper
diagnosis
treatment
critical
components
personalized
precision
medicine.
Hence,
we
conducted
a
cross-sectional
comparative
study
to
evaluate
Ca,
P,
Vit-D
levels
in
non-skeletal
functions
association
with
health
biomarkers
adolescents
diverse
chronic
conditions.
We
performed
anthropometric,
body
composition,
clinical
evaluation,
biochemical
analysis,
dietary
survey
methods.
A
total
78
patients
(1–19
years,
43
females,
42
children)
took
part
this
study.
Overall,
24,
30,
24
participants
were
obese,
undernourished,
eutrophic,
respectively.
Results
found
that
74%
35%
individuals
had
deficient
Ca
intake,
Most
cases
normocalcemic.
also
47%
subjects
deficiency
(VDD),
37%
insufficient,
hypophosphatemia.
Of
46%
31%
VDD
insufficient
levels,
19%
11%
hypophosphatemic,
Calcium,
associated
anthropometric
parameters,
mass
index,
physical
activity,
diet,
hormones,
immune,
liver,
kidney
systems.
These
results
show
coincident
risk
altered
metabolism
diseases.
Endocrine,
Год журнала:
2023,
Номер
82(3), С. 536 - 541
Опубликована: Авг. 17, 2023
Abstract
Purpose
Low
vitamin
D
levels
were
reported
to
negatively
influence
the
outcome
of
acute
COVID-19,
as
well
be
linked
Long-COVID.
However,
few
studies
have
investigated,
so
far,
its
effects
on
humoral-response
anti-SARS-CoV-2
vaccination,
reporting
conflicting
results.
We
aimed
evaluate
impact
baseline
25(OH)vitamin
(25(OH)D)
a
two-dose
cycle
Pfizer-BioNTech-vaccine
up
9–10
months
after
immunization.
Methods
retrospectively
included
119
consecutive
healthcare-workers
(median
age
53
years)
without
previous
history
COVID-19
or
immunoglobulins
presence
immunized
with
two
doses
Comirnaty-vaccine
from
January
February
2021.
25(OH)D
was
measured
at
time
first-immunization.
Immune
response
evaluated
at:
0
(T0),
before
first-dose;
T1,
second-dose
(21
days
T0);
T2,
T3,
T4
1,
5
and
9
respectively.
Results
Median
25.6
ng/mL,
deficiency
(25(OH)D
<20
ng/mL)
observed
in
29
subjects
(24.8%).
In
those
deficiency,
we
found
non-significant
trend
towards
lower
antibody-titers
significantly
titers
compared
not
D-deficient,
also
observing
more
pronounced
negative
drop
peak-T2
deficiency.
A
positive
correlation
between
(
p
=
0.043)
found.
multiple
linear-regression
analysis,
older-age
resulted
independent
factors
associated
antibody
titer
0.026,
0.004;
respectively).
Conclusion
our
relatively
young
cohort
presenting
low
prevalence
hypovitaminosis
D,
long-term
humoral
vaccination
influenced
by
25(OH)D.
Vitamin
supplementation
could
tested
strategy
optimize
campaigns
prevent
severe
COVID-19.
Nutrients,
Год журнала:
2023,
Номер
15(12), С. 2690 - 2690
Опубликована: Июнь 9, 2023
The
association
between
serum
vitamin
D
levels
and
urinary
tract
infection
(UTI)
in
children
is
unclear.
We
undertook
a
systematic
review
meta-analysis
to
evaluate
the
relationships
different
likelihood
of
UTI
children.
Online
databases,
including
Web
Science,
PubMed,
Embase,
Cochrane
Library,
were
searched
up
6
February
2023
for
studies
based
on
inclusion
criteria.
Weighted
mean
difference
(WMD)
Odds
Ratios
(ORs),
along
with
their
95%
confidence
intervals
(CI),
calculated,
random-effects
model
was
used
analysis.
Twelve
case–control
one
cross-sectional
study
(839
929
controls)
included.
found
that
had
lower
than
healthy
controls
(WMD:
−7.730,
CI:
−11.57,
−3.89;
p
<
0.001).
Low
significantly
associated
(OR:
2.80;
1.55,
5.05;
=
having
increased
when
level
less
20
ng/mL
5.49,
1.12,
27.04;
0.036).
Therefore,
level,
especially
ng/mL,
risk
factor
UTI.
Inflammopharmacology,
Год журнала:
2023,
Номер
32(1), С. 249 - 271
Опубликована: Ноя. 13, 2023
Abstract
Nearly
four
years
after
its
first
appearance,
and
having
gone
from
pandemic
to
endemic,
the
SARS-CoV-2
remains
out
of
control
globally.
The
purpose
this
study
was
evaluate
clinical
efficacy
vitamin
D
(VD)
in
COVID-19
long
COVID-19,
explain
discrepancy
outcomes
highlight
potential
impact
metformin
on
VD
recent
articles.
Articles
January
2022
August
2023
were
selected
for
review.
objective
achieved
by
reviewing,
analyzing,
discussing
articles
demonstrating
(1)
mechanism
action
(2)
observational
or
randomized
trials
(RCTs)
that
support
not
beneficial
effects
COVID.
(3)
genetic
non-genetic
reasons
variation
VD.
collected
electronic
databases
such
as
PubMed,
Scopus,
MEDLINE,
Google
Scholar,
Egyptian
Knowledge
Bank,
Science
Direct,
Cochrane
Database
Systematic
Reviews.
Twenty
three
studies
conducted
vitro
animal
models
indicated
may
act
through
protecting
respiratory
system
antimicrobial
peptide
cathelicidins,
reducing
lung
inflammation,
regulating
innate
adaptive
immune
functions
up
regulation
autophagy
gene
activity.
Our
review
identified
58
met
criteria.
number
publications
supporting
a
activity
treating
49
(86%),
including
12
meta-analyses.
Although
total
patients
included
all
14,071,273,
role
14,029,411
(99.7%).
Collectively,
extensive
decisive
relationship
between
low
levels
severity
mortality
outcomes.
Importantly,
evidence
intervention
has
demonstrated
effectiveness
supplements
COVID-19.
Furthermore,
results
4
supported
alleviating
symptoms
disease.
However,
eight
RCTs
one
meta-analysis
contain
low-grade
against
Twenty-five
have
addressed
association
VDR
DBP
polymorphisms
treatment
failure
Impaired
signaling
underlie
variability
mechanisms.
Interestingly,
studies,
therapeutic
possibly
improving
AMPK
enhancing
In
conclusion,
been
significantly
strengthened
over
past
18
months,
with
several
meta-analyses
reporting
conclusive
supplementation
highlighting
improve
sensitivity